glp-1 news 2025 october 21 When Joshua Hunt (@viajoshhunt) started Ozempic in April 2025 GLP-1 makers could be under

Researchers hypothesized that a gastric peptide factor might be involved in maintaining bone health, which partly explains the rationale for studying BPC-157 in bone healing contexts

however, serum d-ROM levels were significantly lower 3 and 6 months after therapy initiation compared with before the treatment

Lacarnit Injection is usually a safe medicine, however, it may cause nausea, vomiting, diarrhea, abdominal pain, and reactions at the site of injection such as swelling, redness, and pain

However, the intricate mechanistic interplay between the immune systems failure to effectively clear senescent cells, the damaging effects of iron-induced oxidative stress, and the subsequent fibrotic remodelling is still poorly understood

Then they assessed the inhibitors pharmacokinetic properties with the group of Professor Robert Rieben (University of Bern)

Bustamante C